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Abstract
An age-dependent association between variation at the FTO locus and BMI in children has been suggested. We meta-
analyzed associations between the FTO locus (rs9939609) and BMI in samples, aged from early infancy to 13 years, from 8
cohorts of European ancestry. We found a positive association between additional minor (A) alleles and BMI from 5.5 years
onwards, but an inverse association below age 2.5 years. Modelling median BMI curves for each genotype using the LMS
method, we found that carriers of minor alleles showed lower BMI in infancy, earlier adiposity rebound (AR), and higher BMI
later in childhood. Differences by allele were consistent with two independent processes: earlier AR equivalent to
accelerating developmental age by 2.37% (95% CI 1.87, 2.87, p = 10220) per A allele and a positive age by genotype
interaction such that BMI increased faster with age (p = 10223). We also fitted a linear mixed effects model to relate
genotype to the BMI curve inflection points adiposity peak (AP) in infancy and AR. Carriage of two minor alleles at
rs9939609 was associated with lower BMI at AP (20.40% (95% CI: 20.74, 20.06), p = 0.02), higher BMI at AR (0.93% (95% CI:
0.22, 1.64), p = 0.01), and earlier AR (24.72% (25.81, 23.63), p = 10217), supporting cross-sectional results. Overall, we
confirm the expected association between variation at rs9939609 and BMI in childhood, but only after an inverse association
between the same variant and BMI in infancy. Patterns are consistent with a shift on the developmental scale, which is
reflected in association with the timing of AR rather than just a global increase in BMI. Results provide important
information about longitudinal gene effects and about the role of FTO in adiposity. The associated shifts in developmental
timing have clinical importance with respect to known relationships between AR and both later-life BMI and metabolic
disease risk.
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Introduction
Genome-wide association studies on body mass index (BMI) and
adiposity have reliably identified its association with variation at
the fat mass and obesity related locus (FTO) in adult and child
populations [1–5]. In meta-analyses, the addition of each minor
(A) allele at the single nucleotide polymorphism (SNP) rs9939609
within the first intron of FTO has been shown to be associated with
a higher BMI of up to 0.33 kg/m2 or approximately 0.1 standard
deviations [2,6]. The biological mechanisms behind this associa-
tion are yet to be fully determined, however evidence from both
population based analyses and functional investigations have
suggested that this locus is likely involved in the hypothalamic
regulation of appetite or energy expenditure and metabolic rate
[7–13]. Indeed, following a series of investigations noting the
correlation between differential Fto expression, fat mass, food
consumption [14,15] and of raised FTO mRNA levels in the
subcutaneous adipose tissue of obese individuals [16–18],
ubiquitous overexpression of Fto has been shown recently to lead
to a dose-dependent increase in body and fat mass irrespective of
diet type [19]. Coincident observation of increases in dietary
consumption, reduced leptin levels and further studies showing
high expression levels in cerebellum, hippocampus and hypothal-
amus [11,20,21], point towards an important role for Fto/FTO in
the regulation of dietary intake.
Until recently, most replication efforts concentrating on
variation in FTO have employed singlepoint analyses of cross-
sectional data. These have been conducted from ages as low as 2
weeks to old age (.70 years) and have demonstrated, with
differing degrees of reliability, associations between variation at
FTO, BMI and related traits [22,23]. Although limited, available
evidence suggests that the cross-sectional FTO/BMI association
varies by age [24–26]. Specifically, at early ages up to and around
7 years, the association between common variation at FTO and
BMI appears to be reduced in magnitude, with smaller studies
being unable to detect association [24–26]. This pattern then
changes in early adulthood with peak effect sizes (approximately
0.3kg/m2/minor allele) occurring by age 20 [24,26]. Following
this peak, this association appears to diminish absolutely (not
relatively) in a manner one would expect for coincident reduction
in adiposity levels with later age [23].
Haworth et al simultaneously examined the FTO/BMI
association and the heritability of BMI in a longitudinal twin
collection with data at ages 4, 7, 10 and 11 years [25]. They found
that the association between BMI and variation at FTO was age
dependent, that the heritability for BMI increased with age and
that the proportion of variance in BMI explained by shared
environment diminished over the same period. Consistent with the
idea that BMI and adiposity related traits may be determined by a
complex interplay between genetic and environmental features,
these findings suggest that with age and dietary autonomy, loci
such as FTO may be able to exert a greater effect on BMI. A
Finnish twin study has since suggested an increase in the
heritability of BMI throughout adolescent years [27].
Individuals vary considerably in their rate of growth and differ in
their rate of development so that some children mature faster and
reach milestones such as puberty earlier [28]. These two processes
can be distinguished from each other. For example most inter-
individual variability in pubertal height velocity can be explained
in terms of developmental age/timing and adjusting for this allows
their growth velocity curves to be superimposed [29]. So if
developmental age explains variability in pubertal height, might it
also explain BMI variability in childhood?
The timing of BMI adiposity rebound (AR) is inversely related
to the risk of later obesity [30–34], and it is also positively
correlated with the timing of puberty [35]. In terms of adiposity,
the age of AR can be viewed as a developmental marker and an
early AR implies an advanced developmental age [36]. This
suggests that variation in the pattern of BMI development may
arise from differences on the developmental age scale that are both
independent of and in addition to differences on the BMI scale. In
fact, there is good evidence to suggest that different processes are
involved in the pattern of high BMI throughout life as opposed to
high adult BMI preceded by average or low BMI in infancy
followed by early AR [36].
Despite the published work on longitudinal differences in the
associations between the variation at FTO and BMI or related
traits, lack of dense lifecourse data and inadequate statistical power
has made interpretation of findings difficult. In this investigation,
we aimed to assess the relationship between variation at rs9939609
and changes in BMI from after birth until 13 years of age, by
meta-analysing data from eight cohorts. We also aimed to explore
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the possibility of differences in developmental age between FTO
genotypes by scaling the ages for each genotype appropriately, so
as to minimise the differences in the pattern of BMI development
through childhood. Lastly, we aimed to fit individual growth
curves in order to explore directly the relationship of this variant to
critical change points in BMI; all features known to be related to
health in later life [36–40].
Results
Cross-sectional results
For the eight studies in the cross-sectional meta-analysis of the
association between rs9939609 and BMI, the average sample size
per age stratum was 9143. Table 1 gives the stratum and study-
specific subject characteristics. Genotypic frequencies at
rs9939609 were broadly consistent across studies and in
accordance with expectations for population samples of European
origin. All genotypic sampling adhered to Hardy Weinberg
equilibrium (Table S1).
In meta-analyses above the age of 5.5 years (childhood) the minor
allele (A) was associated additively with a higher BMI, though this
was not detectable in the age stratum 11 to 13 years where the
sample was small and where age associated increase in variance
compromises analytical power. Expressed as a percentage change,
the additive effect of each minor allele (A) was 0.7% (95% CI: 0.3,
1.1), 1.0% (95% CI: 0.6, 1.3), and 1.3% (95% CI: 0.6, 2.0) at 5.5–7,
7–9 and 9–11 years respectively. Maximum heterogeneity was high
with I2 = 69.6% (95% CI: 22, 88). In contrast to this, each minor
allele was associated with a lower BMI before the age of 2.5 years.
The additive effect of each minor allele was20.4% (95% CI:20.6,
20.1),20.3% (95% C%I:20.6,20.1) and20.3% (95% CI:20.5,
0.0) at age 0–0.5, 0.5–1.5 and 1.5–2.5 years respectively. Between
2.5 and 5.5 years there was no association between rs9939609
genotype and BMI. For these periods, maximum heterogeneity was
high with I2 = 44.1% (95% CI: 0, 81). Figure 1 shows meta-analysis
results representing major observations throughout the age range.
Similar results (not shown) were found for weight/heightp.
To clarify the age trends in BMI for each genotype, median
curves were estimated using the LMS method to adjust for age-
specific heteroscedasticity and skewness. Figure 2 shows the median
curves by genotype, where comparison shows three distinct features:
(i) BMI is higher for A carriers later in childhood, but lower early in
childhood; (ii) AR is earlier for A carriers; (iii) the A allele effects are
additive in that the TA group is consistently midway between AA
and TT. Curves for weight and height (Figure 3) show genotype
differences for weight that emerge only after age 4, and height
differences that are small at all ages. The differences in age at AR
(Figure 2) can be removed by estimating a developmental age
scaling effect per A allele of 2.79% (95% CI: 2.35, 3.23), such that
the age scale in the AA group is shrunk, and in the TT group
stretched, by 2.79% relative to TA. However there remains a rising
BMI trend in AA relative to TT which is confirmed by fitting a log
age by genotype interaction (coefficient 0.039 kg/m2 (0.031, 0.046)
per log age unit per A allele, p = 10223). Fitting the interaction
reduces the optimal age scaling slightly to 2.37% (95% CI: 1.87,
2.87, p = 10220), but provides evidence suggesting that the two
processes together, developmental differences on the age scale and
on the BMI scale, explain the complex age-related genotype effects
on BMI in childhood. Figure 4 shows the estimation of this optimal
scaling (top) and the curves of Figure 2 scaled by this amount
(bottom), where now AR occurs at the same developmental ‘age’ for
all groups. For comparison the optimal age scale to adjust for
genotype differences in height (Figure 3) is 0.3% (0.2, 0.4), a value
attaining statistical confidence, but far smaller than for BMI. Thus
FTO appears to affect BMI developmental age much more than it
does height developmental age.
Longitudinal results
We analysed the richest data sets longitudinally for age and BMI
at adiposity peak (AP) and adiposity rebound (AR). Mean ages at
AP and AR were 0.75 (0.73, 0.78) and 5.70 years (4.56, 6.84) and
mean BMIs 17.87 (17.11, 18.62) and 15.73 kg/m2 (14.66, 16.80)
respectively. There was weak evidence for a lower BMI at AP only
in the carriers of two minor alleles (AA) compared to the reference
group (TT): 20.40% (95%CI: 20.74, 20.06), p = 0.02 (Table 2).
In contrast, there was evidence a per minor allele difference in
BMI of 0.47% (95%CI: 0.17, 0.77) at AR. This was realised as
carriers of two minor alleles (AA) having a 0.93% (95%CI: 0.22,
1.64), p = 0.01 higher BMI at AR than those in the reference group
(TT) (Table 3). There was no evidence for genotypic association
with age at AP, but there was evidence for an additive relationship
between carriage of minor alleles (A) at rs9939609 and earlier AR.
Per minor allele, there was a 22.31% (95%CI: 23.05, 21.57)
difference in age at AR. Indeed, carriers of one minor allele
showed 22.28% earlier AR (95%CI: 23.90, 20.65), p = 0.006
and carriers of two minor alleles 24.72% earlier AR (25.81,
23.63), p = 10217 versus baseline genotype TT). There was
evidence of heterogeneity between cohorts, lower for AP
(maximum I2 30% (0, 74)) than for AR (I2 67% (2, 89)). The
estimated effect on age at AR, and hence the scaling of
developmental age, was very similar with the cross-sectional and
longitudinal data; 2.4% and 2.3% age shrinkage per allele
respectively.
Discussion
We present an investigation into the association of rs9939609
with BMI in infancy and childhood. Results here not only confirm
the increasing magnitude of associations between this variant and
adiposity from the end of infancy through to childhood, but also
suggest an inverse association at early ages—an event intimately
linked with the timing of AR. With resolution afforded by a large
sample size and dense anthropometry data, we have been able to
Author Summary
Variation at the FTO locus is reliably associated with BMI
and adiposity-related traits, but little is still known about
the effects of variation at this gene, particularly in children.
We have examined a large collection of samples for which
both genotypes at rs9939609 and multiple measurements
of BMI are available. We observe a positive association
between the minor allele (A) at rs9939609 and BMI
emerging in childhood that has the characteristics of a
shift in the age scale leading simultaneously to lower BMI
during infancy and higher BMI in childhood. Assessed in
cross section and longitudinally, we find evidence of
variation at rs9939609 being associated with the timing of
AR and the concert of events expected with such a change
to the BMI curve. Importantly, the apparently negative
association between the minor allele (A) and BMI in early
life, which is then followed by an earlier AR and greater
BMI in childhood, is a pattern known to be associated with
both the risk of adult BMI and metabolic disorders such as
type 2 diabetes (T2D). These findings are important in our
understanding of the contribution of FTO to adiposity, but
also in light of efforts to appreciate genetic effects in a
lifecourse context.
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Table 1. Numbers and characteristics of subjects by cohort and age stratum.
Age Stratum (years) Cohort N Age (years) Weight (kg) Height (cm) BMI (kg/m2) Boys (%)
0–0.49* ALSPAC 6512 0.15 (0.03) 5.05 (0.7) 57.67 (2.50) 15.16 (1.5) 50.9
BCG 567 0.24 (0.03) 6.08 (0.7) 60.50 (2.4) 16.61 (1.4) 54.0
GENR 2545 0.16 (0.08) 5.30 (1.01) 57.88 (3.5) 15.8 (1.5) 50.5
NFBC1966 2954 0.26 (0.08) 6.15 (1.09) 61.61 (3.3) 16.2 (1.6) 49.4
UFS 569 0.25 (0.02) 6.13 (0.72) 61.30 (2.4) 16.32 (1.4) 51.1
Stratum total 13147
0.5–1.49 ALSPAC 6402 0.80 (0.11) 9.27 (1.12) 72.65 (3.20) 17.53 (1.60) 50.7
BCG 566 1.00 (0.04) 10.3 (1.19) 74.87 (2.62) 18.38 (1.67) 54.1
GENR 2760 0.94 (0.12) 9.67 (1.05) 74.69 (3.15) 17.33 (1.05) 50.6
NFBC1966 3461 0.99 (0.11) 10.14 (1.18) 75.52 (2.94) 17.78 (1.76) 49.3
RAINE 1012 1.14 (0.09) 10.25 (1.27) 77.48 (2.86) 17.08 (1.27) 52.2
UFS 571 1.00 (0.07) 10.11 (1.19) 75.92 (2.87) 17.54 (1.43) 51.3
Stratum total 14772
1.5–2.49 ALSPAC 4622 1.72 (0.20) 11.96 (1.36) 84.13 (3.88) 16.88 (1.50) 51.2
BCG 548 1.99 (0.13) 12.72 (1.40) 85.52 (3.28) 17.39 (1.40) 54.2
GENR 2395 2.02 (0.20) 12.69 (1.47) 87.69 (3.92) 16.50 (1.47) 50.3
NFBC1966 2585 1.98 (0.16) 11.87 (1.02) 84.03 (3.05) 16.81 (1.02) 49.6
RAINE 326 2.14 (0.12) 12.88 (1.44) 89.91 (3.61) 15.94 (1.26) 50.3
UFS 483 1.81 (0.26) 12.49 (1.54) 85.97 (3.74) 16.9 (1.32) 52.6
Stratum total 10959
2.5–3.49 ALSPAC 735 2.59 (0.02) 13.95 (1.63) 91.56 (3.25) 16.61 (1.27) 51.6
BCG 548 3.01 (0.11) 14.65 (1.64) 94.08 (3.75) 16.55 (1.40) 53.3
GENR 787 2.60 (0.08) 13.97 (1.68) 92.97 (3.65) 16.16 (1.12) 50.6
NFBC1966 2159 3.02 (0.19) 14.33 (1.86) 94.48 (4.18) 16.06 (1.39) 48.3
RAINE 733 3.09 (0.09) 14.98 (1.90) 96.36 (3.80) 16.13 (1.35) 50.6
UFS 503 3.03 (1.01) 15.43 (1.79) 96.75 (3.81) 16.49 (1.35) 51.1
Stratum total 5465
3.5–4.49 ALSPAC 4794 3.72 (0.19) 16.44 (2.077) 100.44 (4.15) 16.26 (1.38) 50.7
BCG 547 4.01 (0.13) 16.75 (1.87) 101.13 (3.98) 16.38 (1.17) 53.6
NFBC1966 2122 4.02 (0.19) 16.23 (1.84) 101.71 (4.15) 15.69 (1.38) 46.9
UFS 525 4.04 (0.10) 17.65 (2.06) 104.53 (4.35) 16.15 (1.37) 51.6
Stratum total 7988
4.5–5.49 ALSPAC 679 5.17 (0.06) 19.46 (2.35) 110.27 (4.43) 15.96 (1.30) 51.5
BCG 560 5.00 (0.08) 18.71 (2.13) 107.32 (4.26) 16.24 (1.42) 53.6
NFBC1966 1901 5.02 (0.20) 18.11 (2.18) 108.37 (4.80) 15.42 (1.31) 46.3
UFS 151 5.13 (0.32) 20.08 (3.195) 111.83 (5.16) 16.05 (1.60) 51.0
Stratum total 3291
5.5–6.99 EBS 714 6.44 (0.37) 23.39 (3.74) 118.75 (5.34) 16.59 (1.60) 50.3
NFBC1966 2759 6.34 (0.35) 20.86 (3.15) 116.62 (5.25) 15.33 (1.58) 48.9
RAINE 984 5.90 (0.18) 21.16 (2.82) 116.00 (4.71) 15.73 (1.57) 52.2
UFS 500 6.02 (0.49) 22.19 (3.35) 118.14 (5.81) 15.90 (1.57) 50.4
Stratum total 4957
7–8.99 ALSPAC 5549 7.83 (0.47) 26.72 (4.47) 127.49 (5.96) 16.35 (2.23) 50.8
EBS 1350 8.02 (0.59) 27.97 (5.14) 127.90 (6.25) 17.09 (2.20) 49.2
NFBC1966 3261 7.82 (0.38) 24.33 (3.43) 124.60 (5.71) 15.68 (1.71) 50.2
RAINE 986 8.10 (0.31) 27.82 (5.024) 129.34 (5.65) 16.63 (2.20) 52.0
UFS 510 7.84 (0.52) 27.23 (5.194) 129.14 (6.32) 16.29 (2.03) 51.6
Stratum total 11656
9–10.99 ALSPAC 5159 9.94 (0.33) 34.63 (7.18) 139.73 (6.46) 17.63 (2.87) 49.9
CH 545 10.26 (0.33) 33.19 (3.97) 138.72 (5.37) 17.25 (1.40) 100
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demonstrate that rather than a null association between the
rs9939609 adult adiposity associated variant and BMI before the
age of 2.5 years, each extra minor (A) allele at this locus is
associated with lower BMI. After the age of 5.5 years a positive
association between rs9939609 and BMI emerges as seen in
previous work [24]. However this study reveals further details of
the association by examining the genotype-specific trends. Thus
the two additive effects of the A allele are to accelerate
developmental age by around 2.4% per allele, corresponding to
an early AR, and at the same time to increase BMI accretion by
about 0.1 kg/m2 per allele from 1 to 13 years. This is confirmed in
longitudinal modelling of our richest data. High levels of adult
BMI may be preceded by either raised BMI throughout
childhood, or alternatively normal or low BMI during infancy
with an early AR and steep climb to high adult BMI [36]. Results
from this work suggest that, rather than predisposing to elevated
adipose levels across the lifecourse, variation at FTO is associated
with a shift in the timing of AR, and is entirely consistent with both
the contrast between patterns of association between infancy and
childhood and the later life BMI associations by which this locus
was discovered [2].
The changing associations between rs9939609 and BMI over
the course of infancy and childhood are consistent with what is
known about the biology of this locus. It has been suggested
previously that energy balance through early life may exert an
influence on the timing of AR [36,41,42]. If FTO is operating
through an influence on appetite and the amount of food
consumed [7–9,13,14,19], then it may be that as individuals are
able to autonomously regulate dietary intake (and other relevant
behavioural traits such as activity), realised differences in appetite
will have an impact on the age at AR. Alternatively, before this
period, it may be that differential metabolic activity according to
genotype exerts influence on the patterns and timing of BMI
change [10]. These possibilities reflect an anticipated interplay
between genetic and environmental factors supported also by the
only simultaneous study of the heritability and genetics of BMI to
date [25]. Beyond this and without further functional understand-
ing as to the action of the FTO locus, it is difficult to speculate as to
the mechanism by which variation at this locus might lead to
earlier AR.
Considering the implications of these findings, rapid early
weight gain is a known risk factor for later obesity [43–45] and
since weight gain is calculated as weight increment divided by time
interval, shortening the developmental time interval has the same
impact on gain as increasing the increment. More directly, earlier
AR has been consistently associated with higher BMI and the risk
of obesity in later life [30–32,34]. Furthermore, this relationship
has been shown to be both incremental [33] and predictive of
downstream risk of diseases such as T2D and coronary heart
disease [46,47]. Overall, whilst the impact of AR being ,5%
earlier for AA carriers may be relatively small, the ultimate impact
on BMI trajectory may have important lifecourse effects which go
some way to explain the known associations between this genotype
and the binary phenotype ‘‘obesity’’. Secondary effects of such
relationships may also be seen in features such as early puberty
which is known to be associated with greater adiposity [48,49] and
corresponds to an advanced developmental age. This is in
accordance with our second finding, that in addition to the earlier
AR associated with minor allele carriage, BMI in this group is low
early on, but subsequently rises faster. Thus we predict that
suitably powered studies of BMI around puberty will show the
minor allele at rs9939609 associated both with earlier puberty and
greater adiposity.
Although FTO impacts on developmental age it is important to
stress that it applies to BMI and not to height. There are only
minor differences in height growth between the three genotype
groups (Figure 3), and they correspond to an age scaling per A
allele of just 0.3%, which is only an eighth of the BMI age scaling
effect. Thus it is not a generalised maturation effect but specific to
adiposity accretion.
Despite the strengths of this study, it has limitations. Firstly, the
definition of age windows in longitudinal analysis may not be
optimal. There are still age groups for which we have limited data
and this is reflected in the sampling error associated with these
periods of growth and development. Furthermore, although the
ability to examine the influence of this locus at different ages is aided
by an analysis of many samples, the stratum specific estimates and
their error terms are subject to the different measurement
techniques and ages. The availability of further collections with
broad age ranges and dense growth data and genotyping would
increase the precision of findings documented here.
Secondly, a possible complication to the patterns of association
seen between common variation at the FTO gene and BMI relates
to the interplay between maternal and offspring genotypes. Whilst
not within the bounds of this paper, the observation that mothers
with greater BMI have, on average, offspring with greater
birthweight who go on to be larger may be relevant in our
interpretation of results [50–56]. Owing to the correlation between
Age Stratum (years) Cohort N Age (years) Weight (kg) Height (cm) BMI (kg/m2) Boys (%)
NFBC1966 2602 10.06 (0.42) 31.43 (5.61) 137.43 (6.63) 16.64 (2.04) 50.6
RAINE 945 10.57 (0.14) 37.87 (7.99) 143.68 (6.46) 18.34 (3.07) 52.4
UFS 510 10.51 (0.45) 35.36 (7.001) 142.22 (6.77) 17.48 (2.48) 51.6
Stratum total 9761
11–13 ALSPAC 4635 11.75 (0.22) 43.26 (9.53) 150.63 (7.49) 18.94 (3.40) 49.3
CH 811 12.01 (0.11) 38.67 (4.84) 146.63 (5.98) 17.99 (1.42) 100
NFBC1966 3389 11.88 (0.36) 37.99 (6.99) 147.32 (7.57) 17.50 (2.329) 50.3
UFS 339 12.03 (0.50) 43.47 (9.022) 153.46 (8.10) 18.45 (2.76) 52.2
Stratum total 9174
Subjects are all singletons of Caucasian ethnicity with FTO (rs9939609) genotype and weight/height information available. Values represent means and standard
deviation.
doi:10.1371/journal.pgen.1001307.t001
Table 1. Cont.
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Figure 1. Results of the meta-analyses of the association between each additional minor allele (A) at rs9939609 and BMI by age
(1a–1j). Figures are shown in units of lnBMI—to convert to percentages multiply by 100. Maximum heterogeneity in meta-analyses was I2 81.7%
(95% CI: 53, 93).
doi:10.1371/journal.pgen.1001307.g001
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maternal and foetal genotypes, one may hypothesise that, on
average, the elevation of adiposity in mothers carrying minor
alleles at rs9939609 may translate to increased levels of
birthweight or differential growth and development in early ages
as shown observationally [57,58]. This would theoretically counter
the inverse association between minor (A) alleles at rs9939609 and
BMI in offspring at very young ages that we have documented.
Whilst this does not appear to be occurring, proper examination of
this requires further large collections with available maternal
genotypes (Table S2).
Lastly, the value of BMI as an assessment of adiposity at early
ages has been questioned [40,59], although BMI is still commonly
used. In this investigation, we performed sensitivity analyses using
the derived measure weight/heightp [60] to account for this
limitation and found that results were largely consistent with
weight/height2. For this reason and for consistency with later ages
in childhood, we adopted the use of BMI throughout.
Overall, we conducted a large analysis of the association
between common variation at FTO locus and BMI. We have
noted that the effect of this locus appears to be age dependent.
Importantly our results suggest an inversion of the known adult
association between this locus and BMI at ages below 2.5 years, an
observation which is consistent with relationships between
variation in FTO and the timing of AR and which may help
develop understanding of the biological mechanisms behind the
association between common variation at this locus, adiposity
related traits and disease risk. Further, specific, analyses will be
required to confirm the age dependent associations and to
Figure 2. Curves of median BMI by age and genotype at rs9939609, estimated by the LMS method and adjusted for study and sex.
doi:10.1371/journal.pgen.1001307.g002
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investigate the clinical implications of associations between
common genetic variation BMI and the timing of AR.
Materials and Methods
To examine the association between rs9939609 genotype and
BMI from birth to 13 years of age we used the growth
measurements from eight studies (Table 1). All subjects were
unrelated children of white European ancestry, with multiple
births excluded. When multiple siblings were present, only data
from the oldest sibling were used. All studies have previously been
described in detail, but brief descriptions are given below.
The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a prospective birth cohort in Bristol, UK, which recruited
pregnant women with expected delivery dates in 1991–1992 (present
analysis: 7,482 subjects). The Barry Caerphilly Growth Study
(BCG) is a longitudinal study of infants born in the towns of Barry and
Caerphilly in South Wales between 1972 and 1974 (569 subjects).The
Christ’s Hospital Cohort (CH) is a retrospective follow-up study
comprised of former male students between the ages of 10 and 18 years
of Christ’s Hospital School born between 1927 and 1956 (812 subjects).
As part of the Energy Balance Study (EBS), data were collected in
2002 and 2003 on pre-pubertal schoolchildren, ages 4 through 10
years, from north-eastern Scotland (2,604 subjects). The Generation
R Study (GENR) is a prospective birth cohort from early foetal life
onwards based in Rotterdam, the Netherlands; subjects born between
2002 and 2006 (2,851 subjects). The Northern Finland Birth
Cohort 1966 (NFBC1966) is a prospective pregnancy/birth cohort
with expected deliveries in 1966 in the two northernmost provinces of
Finland (3,707 subjects). The Raine Study (RAINE) is a prospective
pregnancy cohort set up in 1989, which recruited pregnant women
from Perth, Western Australia for ultrasound imaging (1,106 subjects).
The Uppsala Family Study Study (UFS) is a multigenerational
study set up in 1995 in Uppsala, Sweden (594 subjects).
In all studies, weight and height were measured during routine
visits at community health centres or research centres. All subjects
(or their parents/guardians) gave informed consent and each study
obtained ethical approval from the local ethical review board. For
further details please see Text S1.
Genotyping and quality control
Genotyping of the rs9939609 was performed directly in all eight
cohorts. DNA was isolated either from buccal swabs, blood or cord
blood. Further details of the studies and of genotyping undertaken
in them can be seen in the Text S1.
Analytical strategy and statistical analysis
Cross-sectional analyses. BMI was defined as weight [kg]/
(height [m])2. For the cross-sectional meta-analysis, growth
measurements were grouped into ten strata: 0.01 to ,0.5 years
(i.e. excluding birth); 0.5-; 1.5-; 2.5-; 3.5-; 4.5-; 5.5-; 7-; 9-; and 11
to,13 years. To approximate normality in each stratum BMI was
natural log transformed before analysis, and effects may be
expressed as percentage changes through multiplication by 100
[61]. To remove outliers stratum-specific Z-scores were created
using the ‘‘zscore’’ package in STATA (version 11, Stata Corp.
Texas, USA) and values exceeding 63 were excluded (height and
weight were cleaned similarly). To examine the association
between FTO genotype and BMI within each stratum
multivariable linear regression was used [62]. Study-specific
effect estimates within each stratum were created assuming an
additive genetic model. These models were adjusted for age
because age varied within each age-stratum and sex. No further
adjustment was done as variation at rs9939609 is unrelated to
birth weight or gestational age [2] and the distribution of
genotypes is assumed to be unrelated to possible environmental
confounders [63]. To take into account known correlations
between BMI and height at early ages, a sensitivity analysis was
done using weight/heightp (p ranging from 1.7 to 2.8), with
estimated stratum- and sex-specific powers p for each study [60].
Basic analyses were performed in Stata 11 (Stata corp.).
Cross-sectional cohort-specific results were meta-analyzed
within each stratum using a random effects model to account for
the existence of heterogeneity between studies. Analyses were
performed using the ‘‘metan’’ package in STATA (version 11,
Stata Corp. Texas, USA).
Curves of median BMI by age were estimated for each of the
three genotypes, using the LMS method to adjust for age-specific
heteroscedasticity and skewness [64]. This was implemented with
the ‘‘gamlss’’ package in R (version 2.11.1) [65]. The median (or
M) curve was modelled as a penalized B-spline in log age with 9
degrees of freedom, with corresponding curves for the coefficient
of variation (S) with 5 d.f. and skewness (L) with 3. Study (as an
eight-level factor) and sex were also adjusted for. Data points with
age ,0.1 years were excluded to improve model convergence. To
illustrate the effect on the curves of a k% age scaling per A allele,
scaled age was defined as age(k)~C|age= exp (k=100|n(A)),
where n(A) is the number of A minor alleles (0, 1 or 2), and C is
such that mean age(k) = mean age. This ensured that the age scale
was foreshortened by k% in the AA group and stretched by k% in
the TT group, each relative to TA, while maintaining the same
mean age.
It is not possible to estimate the optimal age scaling k^ explicitly
by linear regression. Instead a series of six LMS models was fitted
with age scaled by k = 0, 1 … 5%, each with a single median BMI
curve fitted as before as a penalized B-spline curve in log age(k)
with 9 d.f., adjusted for study and sex, and S and L curves with
respectively 5 and 3 d.f. The fitted deviance dev(k) for each model
was plotted against k and a quadratic in k fitted such that
dev(k)~azb|kzc|k2. By differentiation the optimal scaling k^
was given by k^~{b=(2c) with 95% confidence interval (k^{,k^z)
where dev(k^{)~dev(k^z)~dev(k^)zx
2
1(0:95) and x
2
1(0:95)~3:84
[66]. The model was refitted at k^ for confirmation. As a further
stage this age-scaled analysis was repeated including an additive
log age(k) by minor allele interaction, and the value of k^ re-
estimated.
Longitudinal analyses. Modelling BMI longitudinally is
complex due to the adiposity peak in infancy and the increasing
population variance in BMI throughout childhood. For this reason
the data were split into two age windows: 2 weeks to 18 months
(infancy) and 18 months to 13 years (childhood), using the studies
with the most data in these age windows (BCG, GENR,
NFBC1966 and UFS in the first and ALSPAC, RAINE,
NFBC1966 and Uppsala in the second). BMI measurements in
the first two weeks of life were excluded to avoid the period of
weight loss after birth. The change point between infancy and
childhood was set at 18 months primarily on statistical grounds to
lie roughly mid-way between AP and AR.
Figure 3. Curves of median weight (above) and height (below) by age and genotype at rs9939609, estimated by the LMS method
and adjusted for study and sex.
doi:10.1371/journal.pgen.1001307.g003
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Derivation of age and BMI at adiposity peak (AP) and
adiposity rebound (AR)
Age and BMI at AP and AR were derived from cubic models in
age for the two age groups separately, with random effects for the
intercept and slope terms. Sex was also adjusted for, but rs9939609
genotype was ignored in order to estimate the outcomes for
individuals and to then relate them to FTO. Subsequently, sex
interactions with linear and quadratic age were added to the
childhood model (both interactions p,0.01 in ALSPAC and
NFBC1966). The models are written as:
(1) Infancy model:
log (BMI)~b0zb1 Agezb2 Age
2zb3 Age
3z
b4 Sexzu0zu1 Ageð Þze
(2) Childhood model:
log (BMI)~b0zb1 Agezb2Age
2zb3 Age
3zb4 Sexz
b5Age  Sexzb6 Age2  Sexzu0zu1 Ageð Þze
Figure 4. Estimation of the optimal age scaling effect per minor A allele for BMI. Minimum deviance corresponds to a scale factor of 2.4%
(above), and adjusting for this factor synchronises the ages at adiposity rebound by genotype (below).
doi:10.1371/journal.pgen.1001307.g004
Table 2. Differences in age and body mass index (BMI) at adiposity peak (AP) between FTO genotype groups with 95% confidence
interval (95% CI).
Genotype Study % difference in age at AP % difference of BMI at AP
BCG 20.12 (20.56, 0.31) 0.06 (20.85, 0.98)
GENR 0.01 (20.47, 0.48) 20.23 (20.56, 0.11)
TA NFBC1966 20.14 (20.79, 0.52) 0.11 (20.38, 0.61)
UFS 0.47 (0.02, 0.91) 20.50 (21.11, 0.13)
Meta-analysis 0.08 (20.22, 0.37), p =0.6 20.16 (20.41, 0.08), p = 0.2
BCG 20.19 (20.80, 0.42) 21.37 (22.63, 20.09)
GENR 20.05 (20.72, 0.62) 20.50 (20.98, 20.03)
AA NFBC1966 0.71 (20.18, 1.59) 20.26 (20.93, 0.42)
UFS 20.35 (20.94, 0.25) 0.10 (20.72, 0.94)
Meta-analysis 20.06 (20.44, 0.33), p = 0.7 20.40 (20.74, 20.06), p = 0.02
Reference group: genotype TT.
Mean age (years) and BMI (kg/m2) at adiposity peak (AP) were 0.75 (0.73, 0.78) & 17.87 (17.11, 18.62) respectively, estimated from the LME model for all cohorts. Meta-
analysis results for AP parameters are based on random effects models where maximum heterogeneity observed was reflected in I2 29.6%(95%CI 0, 74).
doi:10.1371/journal.pgen.1001307.t002
Table 3. Differences in age and body mass index (BMI) at adiposity rebound (AR) between FTO genotype groups with 95%
confidence interval (95% CI).
Genotype Study % difference in age at AR % difference of BMI at AR
ALSPAC 22.93 (24.09, 21.77) 0.621 (0.157, 1.088)
RAINE 24.47 (27.03, 21.90) 0.414 (0.073, 0.756)
TA NFBC1966 21.17 (22.38, 0.05) 0.518 (20.010, 1.050)
UFS 0.92 (23.76, 5.60) 20.141 (21.480, 1.216)
Meta-analysis 22.28 (23.90, 20.65), p = 0.006 0.47 (0.23, 0.71), p = 10204
ALSPAC 25.72 (27.30, 24.14) 1.256 (0.620, 1.896)
RAINE 24.18 (27.83, 20.52) 0.313 (20.172, 0.799)
AA NFBC1966 23.90 (25.55, 22.25) 1.584 (0.860, 2.314)
UFS 22.50 (28.78, 3.78) 0.266 (21.534, 2.099)
Meta-analysis 24.72 (25.81, 23.63), p = 10217 0.93 (0.22, 1.64), p = 0.01
Reference group: genotype TT.
Mean age (years) and BMI (kg/m2) at adiposity rebound (AR) were 5.70 (4.56, 6.84) & 15.73(14.66, 16.80) respectively, estimated from the LME model for all cohorts.
Meta-analysis results for AR parameters are based on random effects models where maximum heterogeneity observed was reflected in I2 66.7% (95%CI 2, 89).
doi:10.1371/journal.pgen.1001307.t003
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For each participant, predicted BMI at AP and AR (on a grid of
every 0.05 years in infancy and every 0.1 years in childhood) was
calculated using the estimated fixed and random coefficients. Age at
AP was defined as the age at maximum BMI between 0.25 and 1.25
years, and age at AR as the age at minimum BMI between 2.5 and
8.5 years. These cut-off points were chosen based on descriptive
analysis of growth curves in the NFBC1966. The associations
between rs9939609 genotype and these growth parameters were
analyzed using both general and additive genetic models. To
account for uncertainty in the derived parameters, each person’s
data were weighted by the number of measurements within the age
window, and those with fewer than three were excluded. Sensitivity
analyses with gestational age as a further adjustment in the AP
models made no substantive difference to the results (performed in
the NFBC1966). Age at AP and age at AR were analysed without
transformation, but are presented as percentages for comparison
with the cross-sectional results. BMI at AP and AR was log-
transformed due to right skewness, and association results are
reported as percentage differences in BMI between genotypes by
multiplying the log differences by 100. Study-specific association
results between each growth parameter and FTO were meta-
analyzed using random effects models to account for the existence of
heterogeneity between studies using the ‘‘metan’’ package in
STATA (version 11, Stata Corp. Texas, USA).
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